HOUSTON – (COMMERCIAL THREAD) – Please replace the version dated June 10, 2021 with the following corrected version due to several revisions.
The updated version reads as follows:
AEGLE LAUNCHES THE FIRST N95 MASK FEATURING EXCLUSIVE ACTEEV ANTIMICROBIAL FABRIC AND AUTHENTICATION AND TRACEABILITY TECHNOLOGY
Healthtech Company Aims to Tackle Counterfeit PPE Market
Masks are made in Houston, Texas with plans for additional PPE applications
Agle (“The Company”), a US manufacturer of high quality PPE and healthcare technology company, has launched the first N95 and NIOSH certified mask that uses authentication and traceability technology, he said. announced today. Each box and set contains a built-in NFC chip to prevent counterfeiting and ensure that every mask sold is reliable, transparent and genuine.
Aegle’s team includes technologists, industrial designers and healthcare experts, including several with PhDs and national security and technology background. Aegle masks are made nationally in the Houston, Texas metropolitan area, and the company plans to launch and license additional PPE applications of its patent-pending authentication and traceability technology.
Masks will soon be available for businesses, businesses, healthcare facilities, essential workplaces and individuals to purchase from Aegle’s website and Amazon.
“Despite the drop in COVID-19 cases in the United States, the world has changed forever because of COVID-19, with governments, healthcare organizations, businesses and consumers now well aware of the need to maintain a national supply of genuine high quality masks and PPE. Said Thomas Lopez, CTO at Aegle. “We are actively responding to these needs through our healthcare technology solutions and our laser focus on innovating and defining the future of high-tech, high-quality protective medical equipment. Our industry-first authentication and traceability technology is the first step in our broader mission of making medical protective equipment design more secure, transparent and trustworthy. ”
Aegle’s N95 mask is designed with particular attention to physical enhancements and equipment design for safety and comfort. The masks are made from ultralight materials that provide exceptional fit and breathability. Each Aegle N95 mask is designed to effectively secure mask placement, minimize mask movement and provide maximum visibility, helping to reduce inhalation exposure to airborne biological particles such as COVID-19, Bacillus Anthracis and Mycobacterium Tuberculosis.
Exclusive partnerships and impact
Aegle’s N95 Antimicrobial Respirator is developed through the company’s exclusive partnership with Ascend Materials. Ascend Acteev fabric is encrusted with active zinc ions which independent experts have shown contain antiviral and antimicrobial efficacy.
Since its founding in May 2020, Aegle has built strong relationships with industry partners, including non-profit organizations. Project N95 and Get us PPE to serve the global mission of building resilience in U.S. supply chains and strategic PPE reserves. Specific initiatives include:
ProjectN95 and the Patriot Military Family Foundation: Aegle donated tens of thousands of masks to the National Guard for the presidential nomination in January.
Aegle donated over 14,000 masks for COVID-19 relief in India last month, to fight one of the world’s worst epidemics
Aegle is backed by a team of Silicon Valley entrepreneurs and technology investors. Co-founder Andrew Moy said: “Aegle is more than a financial investment. Our team protects the safety and security of all Americans by supporting the relocation of critical manufacturing to the United States. Investing in a technology-based, impact-driven, national PPE manufacturer helps America break down the supply chain bottlenecks that continue to weigh on the global economy as we recover from pandemic and ensuring that we remain prepared for a future health crisis.
Authenticity and traceability
Authentication and traceability technology improves supply chain intelligence to ensure efficient distribution to end users and that PPE is efficient and not counterfeit.
The information available will include internal and third-party test data for all materials used in the production of the product, date of manufacture, expiration date, batch number, and verify that each box is an official Aegle product. Having a layer of security that authenticates that the product was manufactured by Aegle aims to provide transparency across the entire supply chain – distributors, retailers and end consumers.
Aegle’s first manufacturing and distribution center is located in the new 100-acre VEnergy Industrial Park near Brookshire in the Houston, TX metro area, currently designated as an Economic Development HUBZone and Opportunity Zone. The center includes 90,000 square feet of manufacturing space and is adjacent to other major national distribution facilities. Following the launch of its N95 mask, Aegle plans to expand production and build a new industrial warehouse space by the end of this year. Aegle has the capacity to produce more than 20 million masks and plans to create more than 100 jobs in the greater Houston area by the fourth quarter of 2021.
To learn more and buy an Aegle mask, visit aegleco.com.
Aegle (“egg-LEE”) is a healthcare technology manufacturing company that was founded by a team of Silicon Valley entrepreneurs and technology investors in response to the personal protective equipment shortage caused by the COVID-19 pandemic. We combine innovative engineering and technology to provide businesses and consumers with the ability to authenticate our products with proprietary authentication and traceability technology and one-of-a-kind PPE data transparency. Our NIOSH Certified N95 masks are assembled at a HUB / Opportunity area in the Houston Metropolitan City of Brookshire, TX, and we are committed to solving the overwhelming domestic demand for PPE from the federal, state, public and private sectors. Our goal is to provide socially responsible, innovative and high quality products that create and maintain safe working environments while mitigating the risk of infection. For more information, please visit aegleco.com.
About Ascend Performance Materials
Ascend Performance Materials manufactures high performance materials for everyday essentials and new technologies. Our goal is to improve the quality of life and inspire a better future through innovation. Headquartered in Houston, Texas, and with regional offices in Shanghai, Brussels and Detroit, we are a fully integrated hardware solutions provider with eight global manufacturing facilities in the United States, Europe and China. Our global workforce of 2,600 people make the plastics, fabrics, fibers and chemicals used to make safer vehicles, cleaner energy, better medical devices, smarter devices and clothing and more durable consumer goods. We are committed to the safety, sustainability and success of our customers and our communities.
Learn more about Ascend at ascendmaterials.com.
About Acteev: actev.com
Tests show antiviral, antibacterial and antifungal efficacy> 99%1
EPA registered zinc ions embedded in the polymer
Hygroscopic nylon 6,6 fabric attracts moisture which activates zinc ions
Not a topical treatment or coating
Does not depend on silver, copper
Proven efficacy in many final forms:
Knitted and woven fabrics for consumer textiles, upholstery fabrics, uniforms, face masks
Nanofiber, meltblown and spunbond nonwovens for filtration
Engineering plastics for high contact surfaces
1 DISCLAIMER: The Acteev ™ technology has been shown in laboratory tests to destroy SARS-CoV-2, the coronavirus that causes COVID-19, and other pathogens, including H1N1, the coronavirus 229E and Gram-positive and Gram-negative bacteria such as staphylococcus and E. coli. All data presented on this page comes from tests carried out by independent third-party laboratories. Tests carried out on various final shapes. Tests performed by the University of Cambridge revealed a> 3 log (99.9%) reduction in SARS-CoV-2 and H1N1 viruses upon instant contact on a polyamide 66 textile fabric with Acteev technology compared to to a polyamide 66 textile fabric of identical basis weight without Acteev technology. Acteev Protect does not protect users or others against pathogenic bacteria. Not all claims are permitted in all jurisdictions, including the United States. Some device designs are currently under review with the United States Food and Drug Administration. Ascend has more than 15 patent families pending on Acteev technology.